Skip to main content

Rigel Pharmaceuticals Inc

RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001034842

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Rigel Pharmaceuticals Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
123
+2 vs. Q4 2024
Shares held
13.9M
+1.85M (+15.3%) vs. Q4 2024
Total value
$250.2M
+$47.6M (+23.5%) vs. Q4 2024
New holders
23
44 more added
Sold out
21
38 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 123 institutions
Q1 2021: 152 institutionsQ2 2021: 160 institutionsQ3 2021: 163 institutionsQ4 2021: 162 institutionsQ1 2022: 163 institutionsQ2 2022: 135 institutionsQ3 2022: 138 institutionsQ4 2022: 118 institutionsQ1 2023: 125 institutionsQ2 2023: 118 institutionsQ3 2023: 106 institutionsQ4 2023: 113 institutionsQ1 2024: 117 institutionsQ2 2024: 91 institutionsQ3 2024: 93 institutionsQ4 2024: 122 institutionsQ1 2025: 123 institutionsQ2 2025: 126 institutionsQ3 2025: 169 institutionsQ4 2025: 194 institutionsQ1 2026: 159 institutionsQ2 2026: 155 institutions
Value heldQ1 2025: $250.2M
Q1 2021: $493.1MQ2 2021: $614.5MQ3 2021: $499.6MQ4 2021: $365.9MQ1 2022: $405.7MQ2 2022: $157.2MQ3 2022: $150.3MQ4 2022: $163.1MQ1 2023: $148.6MQ2 2023: $142.7MQ3 2023: $114.8MQ4 2023: $154.5MQ1 2024: $164.3MQ2 2024: $85.4MQ3 2024: $192.6MQ4 2024: $203.0MQ1 2025: $250.2MQ2 2025: $260.2MQ3 2025: $425.6MQ4 2025: $690.5MQ1 2026: $432.8MQ2 2026: $640.4M
Institutions holding RIGL and their total value by quarter
QuarterHoldersValue
Q2 2026155$640.4M
Q1 2026159$432.8M
Q4 2025194$690.5M
Q3 2025169$425.6M
Q2 2025126$260.2M
Q1 2025123$250.2M
Q4 2024122$203.0M
Q3 202493$192.6M
Q2 202491$85.4M
Q1 2024117$164.3M
Q4 2023113$154.5M
Q3 2023106$114.8M
Q2 2023118$142.7M
Q1 2023125$148.6M
Q4 2022118$163.1M
Q3 2022138$150.3M
Q2 2022135$157.2M
Q1 2022163$405.7M
Q4 2021162$365.9M
Q3 2021163$499.6M
Q2 2021160$614.5M
Q1 2021152$493.1M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q4 2024.

Institutions holding RIGL in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Nuveen, LLC115,218$2.07M0.00%+115,218New
Zacks Investment Management128,088$2.30M0.02%+42,665+49.9%Added
Bank of America Corp132,437$2.38M0.00%+100,271+311.7%Added
Invesco Ltd.134,072$2.41M0.00%+134,072New
Lazard Asset Management LLC134,363$2.42M0.00%+103,523+335.7%Added
Northern Trust Corp142,459$2.56M0.00%−3,380−2.3%Reduced
Qube Research & Technologies Ltd154,617$2.78M0.00%+36,660+31.1%Added
Connor, Clark & Lunn Investment Management Ltd.157,924$2.84M0.01%+18,796+13.5%Added
Hillsdale Investment Management Inc.192,164$3.46M0.18%+22,064+13.0%Added
Renaissance Technologies LLC201,146$3.62M0.01%−98,563−32.9%Reduced
Marshall Wace, LLP211,748$3.81M0.01%+211,748New
Jacobs Levy Equity Management, Inc217,776$3.92M0.02%+15,687+7.8%Added
CM Management, LLC250,000$4.50M4.52%+7,500+3.1%Added
Geode Capital Management, LLC411,168$7.40M0.00%+9,117+2.3%Added
Assenagon Asset Management S.A.522,781$9.40M0.02%+112,003+27.3%Added
Acadian Asset Management LLC565,045$10.2M0.03%+188,679+50.1%Added
State Street Corp637,034$11.5M0.00%+256,519+67.4%Added
Capitolis Liquid Global Markets LLC693,100$12.5M0.11%+693,100New
Vanguard Group Inc1,028,072$18.5M0.00%+15,141+1.5%Added
Soleus Capital Management, L.P.1,130,679$20.3M1.59%00.0%Unchanged
Armistice Capital, LLC1,516,000$27.3M0.73%+364,000+31.6%Added
Morgan Stanley1,536,987$27.7M0.00%−24,509−1.6%Reduced
BlackRock, Inc.1,732,604$31.2M0.00%−15,503−0.9%Reduced
Norges Bank0$00.00%−129,506−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−85,878−100.0%Sold out
Millennium Management LLC0$00.00%−70,426−100.0%Sold out
HRT Financial LP0$00.00%−68,191−100.0%Sold out
Jane Street Group, LLC0$00.00%−62,528−100.0%Sold out
Universal- Beteiligungs- und Servicegesellschaft mbH0$00.00%−40,200−100.0%Sold out
Jump Financial, LLC0$00.00%−30,035−100.0%Sold out
Citadel Advisors LLC0$00.00%−28,411−100.0%Sold out
Walleye Capital LLC0$00.00%−21,621−100.0%Sold out
Verition Fund Management LLC0$00.00%−15,953−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−15,483−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−13,418−100.0%Sold out
Engineers Gate Manager LP0$00.00%−12,609−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−11,075−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−356−100.0%Sold out
Harbour Investments, Inc.0$00.00%−40−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−37−100.0%Sold out
Crowley Wealth Management, Inc.0$00.00%−20−100.0%Sold out
Macquarie Group Ltd0$00.00%−16,207−100.0%Sold out
Synergy Financial Management, LLC0$00.00%−15−100.0%Sold out
IFP Advisors, Inc0$00.00%−1−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed